BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 7295917)

  • 1. Effects of treatment on circadian rhythms of blood pressure.
    Raftery EB; Millar-Craig MW; Mann S; Balasubramanian V
    Biotelem Patient Monit; 1981; 8(1-2):113-20. PubMed ID: 7295917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparative effects of an alpha 1 and beta 1-2 blocker (labetalol) and a beta-1 blocker (atenolol) in the hypertensive patient].
    Sassard J; Zech PY; Pozet N; Cuisinaud G; Vincent M
    J Pharmacol; 1983; 14 Suppl 2():121-9. PubMed ID: 6355664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative anti-hypertensive effects of labetalol and the combination of oxprenolol and phentolamine.
    Johnson BF; LaBrooy J; Munro-Faure AD
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):783-7. PubMed ID: 791332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Profile on circadian blood pressure and the influencing factors in essential hypertensive patients after treatment].
    Qiu YG; Yao XY; Tao QM; Zheng P; Chen JZ; Zhu JH; Zhang FR; Zheng LR; Zhao LL
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Aug; 25(8):710-4. PubMed ID: 15555399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of 2 beta-blockers on arterial hypertension during pregnancy. Results of a prospective study on 56 pregnant hypertensive women treated with atenolol and labetalol].
    Gérard J; Blazquez G; Lardoux H; Beauséjour B; Faurie C; Rousset D; Flouvat B
    J Gynecol Obstet Biol Reprod (Paris); 1983; 12(8):891-900. PubMed ID: 6672083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypertension and beta-blockers. Are they all the same?
    Raftery EB; Carrageta MO
    Int J Cardiol; 1985 Apr; 7(4):337-46. PubMed ID: 2859251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The effects of treatment with atenolol and benazapril on 24-hour pressure variability].
    Prattichizzo FA; Galetta F
    Minerva Cardioangiol; 1993 Dec; 41(12):587-90. PubMed ID: 8139779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exogenous glucocorticoid eliminates or reverses circadian blood pressure variations.
    Imai Y; Abe K; Sasaki S; Minami N; Munakata M; Nihei M; Sekino H; Yoshinaga K
    J Hypertens; 1989 Feb; 7(2):113-20. PubMed ID: 2926131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood pressure variability: clinical implications and effects of antihypertensive treatment.
    Parati G; Ravogli A; Frattola A; Groppelli A; Ulian L; Santucciu C; Mancia G
    J Hypertens Suppl; 1994 Jul; 12(5):S35-40. PubMed ID: 7965285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Twenty-four-hour ambulatory blood pressure monitoring efficacy of perindopril/indapamide first-line combination in hypertensive patients: the REASON study.
    Mallion JM; Chamontin B; Asmar R; De Leeuw PW; O'Brien E; Duprez D; O'Rourke MF; Rahn KH; Romero R; Battegay E; Hitzenberger G; Safar ME;
    Am J Hypertens; 2004 Mar; 17(3):245-51. PubMed ID: 15001199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of antihypertensive agents on circadian blood pressure and heart rate patterns. Review.
    Sirgo MA; Mills RJ; DeQuattro V
    Arch Intern Med; 1988 Dec; 148(12):2547-52. PubMed ID: 3058070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Atenolol or metoprolol as beta-blocker in the treatment of hypertension].
    van den Born BJ; Brewster LM; Koopmans RP; van Montfrans GA
    Ned Tijdschr Geneeskd; 2005 Aug; 149(32):1808-9. PubMed ID: 16121668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changing the timing of antihypertensive therapy to reduce nocturnal blood pressure in CKD: an 8-week uncontrolled trial.
    Minutolo R; Gabbai FB; Borrelli S; Scigliano R; Trucillo P; Baldanza D; Laurino S; Mascia S; Conte G; De Nicola L
    Am J Kidney Dis; 2007 Dec; 50(6):908-17. PubMed ID: 18037091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ambulatory blood pressure and heart rate during once-daily, randomized, crossover administration of carteolol and atenolol.
    Saito K; Furuta Y; Sano H; Yokoyama M; Fukuzaki H
    Clin Ther; 1994; 16(2):181-90. PubMed ID: 8062314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemodynamic and 24-h blood pressure profile of amlodipine monotherapy.
    Ibrahim MM; el-Boghdadly B; Zaghloul SS
    J Hum Hypertens; 1996 Jul; 10(7):489-94. PubMed ID: 8880565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronopharmacology and its impact on antihypertensive treatment.
    Lemmer B
    Acta Physiol Pharmacol Bulg; 1999; 24(3):71-80. PubMed ID: 10736610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of atrial fibrillation in relation to changing heart rate over time in hypertensive patients: the LIFE study.
    Okin PM; Wachtell K; Kjeldsen SE; Julius S; Lindholm LH; Dahlöf B; Hille DA; Nieminen MS; Edelman JM; Devereux RB
    Circ Arrhythm Electrophysiol; 2008 Dec; 1(5):337-43. PubMed ID: 19808428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circadian rhythms in hypertension.
    Millar-Craig MW; Mann S; Balasubramanian V; Altman DG; Raftery EB
    Scott Med J; 1981 Oct; 26(4):309-14. PubMed ID: 7313681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Circadian rhythms of hemodynamic load on the cardiovascular system in patients with essential hypertension: implication for drug therapy rationale].
    Komarov FI; Ol'binskaia LI; Khapaev VA
    Klin Med (Mosk); 2001; 79(3):52-5. PubMed ID: 11490420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discordant beta-blocker effects on clinic, ambulatory, resting, and exercise hemodynamics in patients with hypertension.
    Beitelshees AL; Zineh I; Yarandi HN; Pauly DF; Johnson JA
    Pharmacotherapy; 2006 Sep; 26(9):1247-54. PubMed ID: 16945046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.